Artificial Intelligence in Ophthalmology: Opportunities & Challenges

Artificial intelligence (AI) is rapidly transforming ophthalmology, particularly in image-based screening, diagnosis, and disease management. This whitepaper explores how machine learning and deep learning algorithms are being applied across key ophthalmic conditions, including diabetic retinopathy, age-related macular degeneration, retinopathy of prematurity, glaucoma, and cataracts. It examines the growing role of AI in fundus photography, OCT […]

The Eye as a Window to Wellness

The eye offers a unique, non-invasive window into systemic health, reflecting early signs of cardiovascular, neurological, metabolic, inflammatory, and oncologic disease. This whitepaper explores how retinal imaging and ocular biomarkers can be used to detect and monitor chronic conditions such as hypertension, stroke, diabetes, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and cancer. It reviews key […]

Tear Proteasome Analysis & Its Role in Early Screening & Staging of Disease

Tear proteomics is emerging as a powerful, non-invasive approach for early disease screening and personalized medicine. This whitepaper examines the molecular composition of tear fluid and its growing role in identifying biomarkers for ocular, systemic, neurodegenerative, metabolic, and oncologic conditions. Drawing on advances in mass spectrometry and proteomic analytics, it outlines how tear-based biomarkers can […]